UD-GENOMED

UD-GENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATAS-FEJLESZTESI ES SZOLGALTATO KFT

corporate_fareorganization

Web page: http://www.ud-genomed.hu

Country: Hungary

UD-GENOMED

- Funding / Projects
  (5)

5 Projects, page 1 of 1

TRANSCOM (The Commercialisation of Transglutaminase.)
assignment_turned_inProject2010 - 2014Partners:University of Debrecen, Ani Biotech Oy, Tampere University, X-Link Limited, Covalab (France) +2 partners
University of Debrecen,
Ani Biotech Oy,
Tampere University,
X-Link Limited,
Covalab (France),
UD-GENOMED,
Aston University
Funder: European Commission Project Code: 251506
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
NR-NET (Control of metabolic and inflammatory pathways by nuclear receptors)
assignment_turned_inProject2013 - 2017Partners:KI, University of Bari Aldo Moro, UD-GENOMED, University of Debrecen, CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE +5 partners
KI,
University of Bari Aldo Moro,
UD-GENOMED,
University of Debrecen,
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE,
UNIMI,
Alexander Fleming Biomedical Sciences Research Center,
UNIL,
University of Leicester,
Diagenode (Belgium)
Funder: European Commission Project Code: 606806
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
TRANSPATH (Transglutaminase in disease: a novel therapeutic target?)
assignment_turned_inProject2011 - 2015Partners:X-Link Limited, UiO, UNIPMN, University of Rome Tor Vergata, Aston University +6 partners
X-Link Limited,
UiO,
UNIPMN,
University of Rome Tor Vergata,
Aston University,
Yeditepe University,
University of Debrecen,
VU,
UD-GENOMED,
VUA,
Covalab (France)
Funder: European Commission Project Code: 289964
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Chromatin3D (Chromatin Dynamics in Development and Disease)
Open Access Mandate for Publications assignment_turned_inProject2015 - 2018Partners:Weizmann Institute of Science, Diagenode (Belgium), FOUNDATION FOR RESEARCH AND TECHNOLOGYHELLAS, ACS, KI +8 partners
Weizmann Institute of Science,
Diagenode (Belgium),
FOUNDATION FOR RESEARCH AND TECHNOLOGYHELLAS,
ACS,
KI,
UD-GENOMED,
IEO,
IIT,
University of Edinburgh,
MOSAIQUES,
LMU,
IDIBELL,
Alexander Fleming Biomedical Sciences Research Center
Funder: European Commission Project Code: 642934
Overall Budget: 3,782,580 EURFunder Contribution: 3,782,580 EUR
The cell nucleus is organized and compartmentalized into a highly ordered structure that contains DNA, RNA, chromosomal and histone proteins which make up a structure called chromatin. The dynamics associated with these various components are responsible for regulating physiological processes and the overall stability of the genome. The destabilization of such regulatory mechanisms that act on the chromatin structure are implicated in pathologies such as cancer. Higher order organization of chromatin results in chromosomes which occupy discrete territories within the cell nucleus. Most nuclear processes occur or at least being initiated onto the chromosomes which makes them the main organizing factors in the nucleus. Several proteins that are involved in the replication of DNA, gene transcription and the processing of RNA are found enriched in discrete focal structures. An emerging question is how these structures assemble and are maintained in the absence of membranes and moreover what are the kinetics of stable binding and/or rapid exchange of their components. The dynamic assembly and modification of chromatin during developmental processes as well as the deregulation of such chromatin dynamics during the onset of disease lacks mechanistic insights at present. To address these questions we have put forward a multidisciplinary approach which involves molecular, cellular and systems level approaches by assembling a group of scientists from academia and industry with cross disciplinary expertise and capabilities.
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
TARGETAMD (Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD))
Open Access Mandate for Publications assignment_turned_inProject2012 - 2018Partners:University of Navarra, UNIGE, MDC, UKA, MAGISTRAT DER STADT WIEN +11 partners
University of Navarra,
UNIGE,
MDC,
UKA,
MAGISTRAT DER STADT WIEN,
Helmholtz Association of German Research Centres,
CNRS,
RWTH,
IGEA SPA,
GenoSafe,
3P,
AmBTU,
HOTSWAP STOCKHOLM AB,
PEI,
UD-GENOMED,
NOVARTIS PHARMA GMBH
Funder: European Commission Project Code: 305134
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

UD-GENOMED

UD-GENOMED

5 Projects, page 1 of 1

TRANSCOM (The Commercialisation of Transglutaminase.)

NR-NET (Control of metabolic and inflammatory pathways by nuclear receptors)

TRANSPATH (Transglutaminase in disease: a novel therapeutic target?)

Chromatin3D (Chromatin Dynamics in Development and Disease)

TARGETAMD (Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD))

Loading